Sato F, Nagasawa S
Faculty of Pharmaceutical Sciences, Hokkaido University, Japan.
Biol Chem Hoppe Seyler. 1988 Sep;369(9):1009-17. doi: 10.1515/bchm3.1988.369.2.1009.
We have investigated the kinin release from human L-kininogen, a poor substrate for plasma kallikrein, by the synergistic action of human PMN elastase and plasma kallikrein. Although PMN elastase alone failed to generate kinin activity from L-kininogen, combination of PMN elastase with plasma kallikrein was found to be effective for the generation of kinin activity from L-kininogen. Two kinds of kinin, bradykinin and Met-Lys-bradykinin, were found to be released from L-kininogen by the synergistic action of PMN elastase and plasma kallikrein. Pretreatment of L-kininogen with PMN elastase facilitated the kinin release by plasma kallikrein, whereas pretreatment of L-kininogen with plasma kallikrein did not allow kinin release by the action of PMN elastase. These results suggested that PMN elastase would act firstly on L-kininogen to form a kinin containing fragment, from which kinin is released by the action of plasma kallikrein. The kinin-containing fragment was isolated by gel filtration and high-performance liquid chromatography of the elastase digest of L-kininogen. The amino-acid analysis and N-terminal amino-acid sequence analysis revealed that the kinin-containing fragment consisted of 26 amino-acid residues and is formed by cleavage of an Ile-Ser and a Ser-His bond of L-kininogen.
我们通过人中性粒细胞弹性蛋白酶(PMN弹性蛋白酶)和血浆激肽释放酶的协同作用,研究了人L-激肽原(一种血浆激肽释放酶的不良底物)中激肽的释放情况。尽管单独的PMN弹性蛋白酶无法从L-激肽原产生激肽活性,但发现PMN弹性蛋白酶与血浆激肽释放酶联合使用对从L-激肽原产生激肽活性是有效的。发现通过PMN弹性蛋白酶和血浆激肽释放酶的协同作用,从L-激肽原释放出两种激肽,即缓激肽和甲硫氨酸-赖氨酸-缓激肽。用PMN弹性蛋白酶预处理L-激肽原促进了血浆激肽释放酶引起的激肽释放,而用血浆激肽释放酶预处理L-激肽原则不允许PMN弹性蛋白酶作用引起激肽释放。这些结果表明,PMN弹性蛋白酶首先作用于L-激肽原形成含激肽的片段,然后血浆激肽释放酶作用于该片段释放出激肽。通过对L-激肽原弹性蛋白酶消化产物进行凝胶过滤和高效液相色谱分离出含激肽的片段。氨基酸分析和N端氨基酸序列分析表明,含激肽的片段由26个氨基酸残基组成,是通过L-激肽原的异亮氨酸-丝氨酸和丝氨酸-组氨酸键的断裂形成的。